Increased maternal leptin levels may be an indicator of subclinical hypotyroidsm in newborn

HANDE KARPUZOGLU

doi:10.5937/jomb0-32425

HANDE KARPUZOGLU Turkish journal of biochemistry

DOI: https://doi.org/10.5937/jomb0-32425

Keywords: leptin, congenital hypothyroidism, maternal-fetal relations, newborn TSH (Thyroid Stimulating Hormone), maternal thyroid hormones

Abstract

Background: Several factors may influence newborn thyroid-stimulating hormone (TSH) concentrations and cause subclinical hypothyroidism in the newborn. A sufficient level of leptin signaling is needed for the normal production of TSH and the production of thyroid hormones by the thyroid gland. In our study, we aimed to investigate the correlation between maternal serum leptin concentration during the third trimester of pregnancy and newborn screening-TSH levels.

Methods: This prospective cross-sectional study was conducted in clinics of obstetrics and gynecology of a state hospital between June and August 2013. Maternal venous blood samples were collected from 270 healthy pregnant women in the third trimester just before delivery. Measurement of maternal fT3, fT4, TSH, anti-thyroid peroxidase (TPO), and anti-thyroglobulin (anti-Tg) antibodies from serum samples were performed by chemiluminescence immunoassay. Maternal serum leptin levels were determined by ELISA. Dried capillary blood spots were used to measure newborn TSH levels.

Results: Subjects were divided into two groups according to the neonatal TSH levels using a cut-point of 5.5 mIU/L. Median maternal serum leptin levels were significantly higher in newborns whose TSH levels were higher than >5.5 mIU/L [13.2 µg/L (1.3 – 46.5) vs. 19.7 µg/L (2.4 – 48.5), p<0.05]. Serum leptin levels showed a negative correlation with maternal fT4 (r=0.32, p<0.05), fT3 (r=0.23, p<0.05), and a positive correlation with BMI (r=0.30 p<0.05).

Conclusion: Our results suggest that high leptin levels in the third trimester of pregnancy influence maternal thyroid functions and might cause and increase in newborn TSH levels. Detection of high maternal serum leptin levels may be a reason for subclinical hypothyroidism.

References

1. Coelho M, Oliveira T, Fernandes R. Biochemistry of adipose tissue: An endocrine organ. Arch Med Sci. 2013;9:191–200.
2. Friedman JM. Leptin and the endocrine control of energy balance. Nat Metab. Springer US; 2019;1.
3. Mantzoros CS. Leptin and the hypothalamus: Neuroendocrine regulation of food intake. Mol Psychiatry. 1999;4:8–12.
4. Rose S.R ATA. Update of newborn screening and therapy for congenital hypothyroidism. Off J Am Acad Pediatrıcs. 2006;2290–303.
5. Blazer S, Moreh-waterman Y, Miller-lotan R, Tamir A, Hochberg Z. Maternal Hypothyroidism May Affect Fetal Growth and Neonatal Thyroid Function. 2003;102:232–41.
6. Trumpff C, Vandevijvere S, Moreno-reyes R, Vanderpas J, Tafforeau J, Oyen H Van, et al. ScienceDirect Neonatal thyroid-stimulating hormone level is influenced by neonatal , maternal , and pregnancy factors. Nutr Res. Elsevier Inc.; 2015;
7. Filis P, Hombach-klonisch S, Ayotte P, Nagrath N, Soffientini U, Klonisch T, et al. Maternal smoking and high BMI disrupt thyroid gland development. BMC Medicine; 2018;1–15.
8. Kahr MK, Antony KM, Delbeccaro M, Hu M, Aagaard KM, Suter MA. Increasing maternal obesity is associated with alterations in both maternal and neonatal thyroid hormone levels. 2016;551–7.
9. Mouzon SH, Lepercq J, Catalano P. The known and unknown of leptin in pregnancy. 2006;
10. Costa MA. The endocrine function of human placenta: An overview. Reprod Biomed Online. Elsevier Ltd; 2016;32:14–43.
11. Schanton M, Maymó JL, Pérez-pérez A, Sánchez-margalet V, Varone CL. placenta. 2015;
12. Donbaloğlu Z, Savaş-Erdeve Ş, Çetinkaya S, Aycan Z. Cases referred from the turkish national screening program: Frequency of congenital hypothyroidism and etiological distribution. JCRPE J Clin Res Pediatr Endocrinol. 2019;11:240–6.
13. Bernal J. Thyroid hormone receptors in brain development. 2007;3:249–59.
14. Morreale de Escobar G, Obregon MJ, Escobar del Rey F. Fetal and maternal thyroid hormones. Horm Res. 1987;26:12–27.
15. Çaylan N, Tezel B, Özbaş S, Şahin N, Aydın Ş, Acıcan D, et al. Neonatal thyroid-stimulating hormone screening as a monitoring tool for iodine deficiency in Turkey. JCRPE J Clin Res Pediatr Endocrinol. 2016;8:187–91.
16. Ng SM, Wong SC, Paize F, Chakkarapani E, Newland P, Didi M. Multivariate analyses of factors that affect neonatal screening thyroid stimulating hormone. 2011;
17. Assessment of iodine deficiency disorders and monitoring their elimination.
18. Antonio P, Maym J, Fern M. Leptin action in normal and pathological pregnancies Leptin mediates the crosstalk between adipose tissue and reproduction Role of leptin in placenta development. 2018;22:716–27.
19. Barrenetxe J. Leptin resistance and diet-induced obesity: central and peripheral actions of leptin. 2015;4.
20. Vitoratos N, Salamalekis E, Kassanos D, Loghis C, Panayotopoulos N, Kouskouni E, et al. Maternal plasma leptin levels and their relationship to insulin and glucose in gestational-onset diabetes. Gynecol Obstet Invest. 2001;51:17–21.
21. Taylor BD, Ness RB, Olsen J, Hougaard DM, Skogstrand K, Roberts JM, et al. Preeclampsia Serum Leptin Measured in Early Pregnancy Is Higher in Women With Preeclampsia Compared With Normotensive Pregnant Women. 2014;594–9.
22. Pop VJ, Biondi B, Wijnen HA, Kuppens SM, Lvader H. Maternal thyroid parameters , body mass index and subsequent weight gain during pregnancy in healthy euthyroid women. 2013;577–83.
23. Sattar N, Greer I, Pirwani I, Gibson J, Michael A, Sattar N, et al. Leptin levels in pregnancy , marker for fat accumulation and mobilization ? Leptin levels in pregnancy : marker for fat accumulation and mobilization ? 2017;6349.
24. Shaarawy M, El-Mallah SY. Leptin and gestational weight gain: Relation of maternal and cord blood leptin to birth weight. J Soc Gynecol Investig. 1999;6:70–3.
25. Sagawa N, Itoh H, Matsumoto T, Mise H, Liu W, Nuamah MA, et al. LEPTIN AS A NOVEL PLACENTA-DERIVED HORMONE IN HUMANS -A Review-. 1999;25–34.
26. Monte S, Valenti O, Giorgio E, Renda E, Hyseni E, Faraci M, et al. Maternal weight gain during pregnancy and neonatal birth weight: a review of the literature. J Prenat Med. 2011;5:27–30.
27. Serapio S, Ahlsson F, Larsson A, Kunovac Kallak T. Second Trimester Maternal Leptin Levels Are Associated with Body Mass Index and Gestational Weight Gain but not Birth Weight of the Infant. Horm Res Paediatr. 2020;92:106–14.
28. Manderson JG, Patterson CC, Hadden DR, Traub AI, Leslie H, McCance DR. Leptin concentrations in maternal serum and cord blood in diabetic and nondiabetic pregnancy. Am J Obstet Gynecol. 2003;188:1326–32.
29. Stefaniak M, Dmoch-Gajzlerska E, Mazurkiewicz B, Gajzlerska-Majewska W. Maternal serum and cord blood leptin concentrations at delivery. PLoS One. 2019;14:1–12.
30. Zimmermann-belsing T, Brabant G, Holst JJ, Feldt-rasmussen U. Circulating leptin and thyroid dysfunction. 2003.
31. Iacobellis G, Ribaudo MC, Zappaterreno A, Iannucci CV, Leonetti F. Relationship of thyroid function with body mass index, leptin, insulin sensitivity and adiponectin in euthyroid obese women. Clin Endocrinol (Oxf). 2005;62:487–91.
32. Bétry C, Challan-Belval MA, Bernard A, Charrié A, Drai J, Laville M, et al. Increased TSH in obesity: Evidence for a BMI-independent association with leptin. Diabetes Metab. Elsevier Masson SAS; 2015;41:248–51.
33. Ökdemir D, Hatipoğlu N, Kurtoğlu S, Siraz ÜG, Akar HH, Muhtaroğlu S, et al. The Role of Irisin, Insulin and Leptin in Maternal and Fetal Interaction. J Clin Res Pediatr Endocrinol. 2018;10:307–15.
34. Mazaki-Tovi S, Kanety H, Pariente C, Hemi R, Wiser A, Schiff E, et al. Maternal serum adiponectin levels during human pregnancy. J Perinatol. 2007;27:77–81.